IBDEI0UY ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15034,1,4,0)
 ;;=4^255.42
 ;;^UTILITY(U,$J,358.3,15034,1,5,0)
 ;;=5^Mineralcorticoid Deficient
 ;;^UTILITY(U,$J,358.3,15034,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,15035,0)
 ;;=259.50^^81^937^2
 ;;^UTILITY(U,$J,358.3,15035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15035,1,4,0)
 ;;=4^259.50
 ;;^UTILITY(U,$J,358.3,15035,1,5,0)
 ;;=5^Androgen Insensitivity,Unspec
 ;;^UTILITY(U,$J,358.3,15035,2)
 ;;=^336738
 ;;^UTILITY(U,$J,358.3,15036,0)
 ;;=275.5^^81^937^18
 ;;^UTILITY(U,$J,358.3,15036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15036,1,4,0)
 ;;=4^275.5
 ;;^UTILITY(U,$J,358.3,15036,1,5,0)
 ;;=5^Hungry Bone Syndrome
 ;;^UTILITY(U,$J,358.3,15036,2)
 ;;=^336538
 ;;^UTILITY(U,$J,358.3,15037,0)
 ;;=793.2^^81^938^3
 ;;^UTILITY(U,$J,358.3,15037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15037,1,4,0)
 ;;=4^793.2
 ;;^UTILITY(U,$J,358.3,15037,1,5,0)
 ;;=5^Abnormal Chest x-ray, other
 ;;^UTILITY(U,$J,358.3,15037,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,15038,0)
 ;;=277.6^^81^938^5
 ;;^UTILITY(U,$J,358.3,15038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15038,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,15038,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,15038,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,15039,0)
 ;;=493.92^^81^938^6
 ;;^UTILITY(U,$J,358.3,15039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15039,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,15039,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,15039,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,15040,0)
 ;;=493.20^^81^938^11
 ;;^UTILITY(U,$J,358.3,15040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15040,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,15040,1,5,0)
 ;;=5^COPD with Asthma
 ;;^UTILITY(U,$J,358.3,15040,2)
 ;;=COPD with Asthma^269964
 ;;^UTILITY(U,$J,358.3,15041,0)
 ;;=493.91^^81^938^7
 ;;^UTILITY(U,$J,358.3,15041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15041,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,15041,1,5,0)
 ;;=5^Asthma, with Status Asthmat
 ;;^UTILITY(U,$J,358.3,15041,2)
 ;;=^269967
 ;;^UTILITY(U,$J,358.3,15042,0)
 ;;=491.21^^81^938^10
 ;;^UTILITY(U,$J,358.3,15042,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15042,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,15042,1,5,0)
 ;;=5^COPD Exacerbation
 ;;^UTILITY(U,$J,358.3,15042,2)
 ;;=COPD Exacerbation^269954
 ;;^UTILITY(U,$J,358.3,15043,0)
 ;;=494.0^^81^938^9
 ;;^UTILITY(U,$J,358.3,15043,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15043,1,4,0)
 ;;=4^494.0
 ;;^UTILITY(U,$J,358.3,15043,1,5,0)
 ;;=5^Bronchiectasis, chronic
 ;;^UTILITY(U,$J,358.3,15043,2)
 ;;=^321990
 ;;^UTILITY(U,$J,358.3,15044,0)
 ;;=494.1^^81^938^8
 ;;^UTILITY(U,$J,358.3,15044,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15044,1,4,0)
 ;;=4^494.1
 ;;^UTILITY(U,$J,358.3,15044,1,5,0)
 ;;=5^Bronchiectasis with exacerb
 ;;^UTILITY(U,$J,358.3,15044,2)
 ;;=^321991
 ;;^UTILITY(U,$J,358.3,15045,0)
 ;;=496.^^81^938^12
 ;;^UTILITY(U,$J,358.3,15045,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15045,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,15045,1,5,0)
 ;;=5^COPD, General
 ;;^UTILITY(U,$J,358.3,15045,2)
 ;;=COPD, General^24355
 ;;^UTILITY(U,$J,358.3,15046,0)
 ;;=491.20^^81^938^13
 ;;^UTILITY(U,$J,358.3,15046,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15046,1,4,0)
 ;;=4^491.20
 ;;^UTILITY(U,$J,358.3,15046,1,5,0)
 ;;=5^Chronic Asthmatic Bronchitis
 ;;^UTILITY(U,$J,358.3,15046,2)
 ;;=Chronic Asthmatic Bronchitis^269953
 ;;^UTILITY(U,$J,358.3,15047,0)
 ;;=491.9^^81^938^14
 ;;^UTILITY(U,$J,358.3,15047,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15047,1,4,0)
 ;;=4^491.9
 ;;
 ;;$END ROU IBDEI0UY
